Mosunetuzumab, the first bispecific approved for follicular lymphoma.
Clin Adv Hematol Oncol
; 21(10): 529-531, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37948588
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Adv Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2023
Type:
Article